Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp57209_8k.htm |
Exhibit 99.1
| Press Release |  |
| www.shire.com |
Notification of major interests in shares
June 18, 2015 - Shire plc (LSE: SHP, NASDAQ: SHPG)
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
|
Shire plc |
| 2. Reason for the notification | State Yes/No |
| An acquisition or disposal of voting rights | Yes |
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
No
|
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
No
|
| An event changing the breakdown of voting rights | No |
| Other (please specify): | No |
| 3. Full name of person(s) subject to the notification obligation: | FMR LLC |
| 4. Full name of shareholder(s) (if different from 3.): | See Section 9 |
| 5. Date of the transaction (and date on which the threshold is crossed or reached if different): | June 17, 2015 |
| 6. Date on which issuer notified: | June 18, 2015 |
| 7. Threshold(s) that is/are crossed or reached: | 5% |
| 8. Notified details: | ||||||||
|
A: Voting rights attached to shares
| ||||||||
|
Class/type of shares
|
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||
| Number of Shares |
Number
|
Number of shares |
Number of voting rights |
% of voting rights | ||||
| Indirect | Direct | Indirect | Direct | Indirect | ||||
|
JE00B2QKY057
|
29,674,746 | 29,674,746 | 29,412,481 | 29,412,481 | 4.96 | |||
|
B: Qualifying Financial Instruments
| ||||
|
Resulting situation after the triggering transaction
| ||||
| Type of financial instrument |
Expiration date |
Exercise/Conversion Period/ Date |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
| ||||||
|
Resulting situation after the triggering transaction
| ||||||
| Type of financial instrument |
Exercise price |
Expiration date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights
| |
| Nominal |
Delta
| |||||
| Total (A+B+C) | |
| Number of voting rights | % of voting rights |
| 29,412,481 | 4.96 |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
| Custodian | Day to Day IM | Total |
| CROSBY ADVS LLC-CROSBY ADVISORS LLC | 25,723 | |
| BANK OF NEW YORK MELLON | PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 347,644 |
| BROWN BROS HARRIMN LTD LUX (C) | FMRC-FMR CO., INC | 3,900 |
| BROWN BROTHERS HARRIMAN AND CO | FMRC-FMR CO., INC | 7,203,490 |
| FMRIMUK-FMR INVESTMENT MANAGEMENT (UK) LIMITED | 57,900 | |
| PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 28,719 | |
| PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY | 721,869 | |
| CIBC MELLON TRUST (C) | PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 22,525 |
| PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY | 17,700 | |
| CITIBANK NA, HONG KONG BR (S) | PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 27,377 |
| DEUTSCHE BANK ALEX BROWN (C) | PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 6,000 |
| JP MORGAN, BOURNEMOUTH (C) | PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 16,574 |
| PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY | 30,831 | |
| JPMORGAN CHASE BANK | FMRC-FMR CO., INC | 8,176,441 |
| FMRIMUK-FMR INVESTMENT MANAGEMENT (UK) LIMITED | 482,300 | |
| PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY | 41,933 | |
| MELLON BANK NA (C) | PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 77,068 |
| MORGAN STANLEY AND CO LLC | PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 2,100 |
| NATIONAL BANK TRUST (C) | PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY | 25,225 |
| NATIONAL FINANCIAL SERVICES(C) | SAI-STRATEGIC ADVISERS, INC. | 1,346 |
| NORTHERN TRUST CO (C) | FMRC-FMR CO., INC | 2,724,688 |
| FMRIMUK-FMR INVESTMENT MANAGEMENT (UK) LIMITED | 1,669,700 | |
| PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 110,800 | |
| PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY | 44,001 | |
| STATE STR BK AND TR CO LNDN (C | PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 34,898 |
| STATE STREET BANK AND TR CO | FMRC-FMR CO., INC | 6,247,251 |
| FMRIMUK-FMR INVESTMENT MANAGEMENT (UK) LIMITED | 449,700 | |
| PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 430,756 | |
| PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY | 351,212 | |
| US BANK NA (C) | PGALLC-PYRAMIS GLOBAL ADVISORS, LLC | 32,810 |
| Grand Total | 29,412,481 |
| Proxy Voting: 10. Name of the proxy holder: |
FMR LLC
|
| 11. Number of voting rights proxy holder will cease to hold: | 262,265 |
| 12. Date on which proxy holder will cease to hold voting rights: | June 17, 2015 |
| 13. Additional information: | None |
| 14. Contact name: | Sally-Ann Hatton |
| 15. Contact telephone number: |
fil-regreporting@fil.com, 01737 837148
|
For further information please contact:
| Investor Relations | ||
| Sarah Elton-Farr | seltonfarr@shire.com | +44 1256 894157 |
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
www.shire.com